US Bancorp’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$797K Buy
8,239
+817
+11% +$83.8K ﹤0.01% 1265
2025
Q4
$788K Sell
7,422
-373
-5% -$43.2K ﹤0.01% 1265
2025
Q3
$990K Buy
7,795
+58
+0.7% +$6.91K ﹤0.01% 1143
2025
Q2
$949K Buy
7,737
+5,370
+227% +$613K ﹤0.01% 1135
2025
Q1
$240K Buy
2,367
+987
+72% +$96.4K ﹤0.01% 1889
2024
Q4
$127K Buy
1,380
+121
+10% +$11.9K ﹤0.01% 2277
2024
Q3
$122K Buy
1,259
+198
+19% +$17.8K ﹤0.01% 2298
2024
Q2
$91K Buy
1,061
+26
+3% +$2.18K ﹤0.01% 2385
2024
Q1
$85.5K Buy
1,035
+10
+1% +$732 ﹤0.01% 2445
2023
Q4
$68.4K Sell
1,025
-482
-32% -$31.2K ﹤0.01% 2507
2023
Q3
$101K Buy
1,507
+461
+44% +$31.7K ﹤0.01% 2143
2023
Q2
$70.8K Sell
1,046
-68
-6% -$4.26K ﹤0.01% 2346
2023
Q1
$60.3K Sell
1,114
-144
-11% -$8.38K ﹤0.01% 2421
2022
Q4
$75.2K Sell
1,258
-1,581
-56% -$86K ﹤0.01% 2318
2022
Q3
$128K Sell
2,839
-5,590
-66% -$280K ﹤0.01% 2077
2022
Q2
$376K Sell
8,429
-3,306
-28% -$170K ﹤0.01% 1584
2022
Q1
$664K Buy
11,735
+4,682
+66% +$244K ﹤0.01% 1390
2021
Q4
$366K Buy
7,053
+143
+2% +$7.38K ﹤0.01% 1688
2021
Q3
$413K Buy
6,910
+123
+2% +$7.74K ﹤0.01% 1620
2021
Q2
$421K Buy
6,787
+258
+4% +$17.2K ﹤0.01% 1636
2021
Q1
$425K Sell
6,529
-718
-10% -$46.8K ﹤0.01% 1584
2020
Q4
$476K Sell
7,247
-211
-3% -$12.4K ﹤0.01% 1461
2020
Q3
$385K Sell
7,458
-172
-2% -$8.83K ﹤0.01% 1463
2020
Q2
$376K Sell
7,630
-26
-0.3% -$1.4K ﹤0.01% 1449
2020
Q1
$390K Sell
7,656
-1,132
-13% -$65.3K ﹤0.01% 1337
2019
Q4
$484K Sell
8,788
-815
-8% -$44.2K ﹤0.01% 1391
2019
Q3
$483K Sell
9,603
-1,709
-15% -$85.9K ﹤0.01% 1386
2019
Q2
$569K Sell
11,312
-6,574
-37% -$319K ﹤0.01% 1335
2019
Q1
$830K Buy
17,886
+1,981
+12% +$100K ﹤0.01% 1161
2018
Q4
$782K Sell
15,905
-1,515
-9% -$86.2K ﹤0.01% 1122
2018
Q3
$1.08M Buy
17,420
+1,795
+11% +$109K ﹤0.01% 1060
2018
Q2
$842K Sell
15,625
-5,774
-27% -$289K ﹤0.01% 1204
2018
Q1
$973K Sell
21,399
-253
-1% -$10.8K ﹤0.01% 1095
2017
Q4
$851K Sell
21,652
-263
-1% -$10K ﹤0.01% 1179
2017
Q3
$808K Buy
21,915
+13
+0.1% +$463 ﹤0.01% 1188
2017
Q2
$844K Sell
21,902
-464
-2% -$17K ﹤0.01% 1141
2017
Q1
$762K Sell
22,366
-436
-2% -$14.3K ﹤0.01% 1208
2016
Q4
$748K Buy
22,802
+148
+0.7% +$4.8K ﹤0.01% 1201
2016
Q3
$731K Buy
22,654
+47
+0.2% +$1.52K ﹤0.01% 1180
2016
Q2
$698K Buy
22,607
+332
+1% +$10.4K ﹤0.01% 1176
2016
Q1
$667K Buy
22,275
+11,291
+103% +$312K ﹤0.01% 1177
2015
Q4
$304K Sell
10,984
-16,825
-61% -$479K ﹤0.01% 1520
2015
Q3
$849K Sell
27,809
-490
-2% -$17.1K ﹤0.01% 1056
2015
Q2
$1.04M Sell
28,299
-550
-2% -$19.6K ﹤0.01% 1007
2015
Q1
$1.02M Buy
28,849
+12,412
+76% +$425K ﹤0.01% 1008
2014
Q4
$503K Buy
16,437
+1,861
+13% +$58K ﹤0.01% 1339
2014
Q3
$428K Sell
14,576
-547
-4% -$16.7K ﹤0.01% 1398
2014
Q2
$431K Buy
15,123
+1,296
+9% +$36.1K ﹤0.01% 1427
2014
Q1
$395K Buy
13,827
+233
+2% +$6.07K ﹤0.01% 1448
2013
Q4
$361K Sell
13,594
-1,020
-7% -$28.4K ﹤0.01% 1453
2013
Q3
$401K Buy
14,614
+1,515
+12% +$38.9K ﹤0.01% 1356
2013
Q2
$300K Buy
+13,099
New +$296K ﹤0.01% 1440

Other funds holding EHC

US Bancorp's EHC Position: Q1 2026 in Review

US Bancorp increased its Encompass Health (EHC) stake by 11% in Q1 2026, buying an estimated $83.8K and bringing the position to 8,239 shares worth $797K. The position accounts for ﹤0.01% of the portfolio, ranked #1265.

US Bancorp first reported a position in EHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.08M in Q3 2018. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • US Bancorp held 8,239 shares of Encompass Health worth $797K as of Q1 2026.
  • US Bancorp bought 817 Encompass Health shares in Q1 2026, an estimated $83.8K.
  • Encompass Health made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #1265 holding.
  • US Bancorp first reported a position in Encompass Health in Q2 2013 and has held it in 52 quarters since.
  • US Bancorp's Encompass Health position peaked at $1.08M in Q3 2018.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.